Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Trading Down 2.7% – Should You Sell?

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)’s share price fell 2.7% on Friday . The stock traded as low as $35.39 and last traded at $35.47. Approximately 27,668 shares changed hands during trading, a decline of 6% from the average daily volume of 29,503 shares. The stock had previously closed at $36.45.

Invesco Nasdaq Biotechnology ETF Stock Down 2.7%

The company’s fifty day moving average price is $33.42 and its two-hundred day moving average price is $30.74. The company has a market cap of $83.00 million, a price-to-earnings ratio of 17.03 and a beta of 0.60.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 22nd were given a dividend of $0.0342 per share. The ex-dividend date was Monday, June 22nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.4%.

Hedge Funds Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors have recently bought and sold shares of the business. Osaic Holdings Inc. boosted its stake in Invesco Nasdaq Biotechnology ETF by 28.4% in the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after purchasing an additional 1,052 shares in the last quarter. Ascentis Independent Advisors bought a new stake in shares of Invesco Nasdaq Biotechnology ETF during the first quarter worth $31,000. Royal Bank of Canada acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at $37,000. International Assets Investment Management LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at $41,000. Finally, Advisory Services Network LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF in the third quarter valued at about $52,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.